IDiyas

For the Inventor, By the Inventor

Orinda, CA, United States of America

Daniel Tumas

USPTO Granted Patents = 68 

 

Average Co-Inventor Count = 11.8

ph-index = 15

Forward Citations = 591(Granted Patents)


Inventors with similar research interests:


Company Filing History:

goldMedal62 out of 3,221 
 
Genentech, Inc.
 patents
silverMedal6 out of 98 
 
Genetech, Inc.
 patents

Years Active: 2002-2012

Loading Chart...
Loading Chart...
68 patents (USPTO):Explore Patents
1. 8338132 - Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof (2012-12-25),
2. 8273703 - IL-17 receptor-like polypeptides and therapeutic uses thereof (2012-09-25),
3. 8034342 - Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E (2011-10-11),
4. 7741056 - Use of A33 antigens and JAM-IT (2010-06-22),
5. 7700736 - PRO350 antibodies (2010-04-20),
6. 7601514 - Nucleic acid encoding PRO10268 polypeptides (2009-10-13),
7. 7576182 - Compositions and methods for the treatment of immune related diseases (2009-08-18),
8. 7557192 - Anti-PRO335 antibodies (2009-07-07),
9. 7550573 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2009-06-23),
10. 7470771 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2008-12-30),
11. 7442772 - Antibodies to PRO361 polypeptide (2008-10-28),
12. 7432345 - PRO1475 polypeptide (2008-10-07),
13. 7419663 - Treatment of complement-associated disorders (2008-09-02),
14. 7408042 - Anti-PRO6181 antibodies (2008-08-05),
15. 7390879 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2008-06-24),

Certainly! Here is the article about inventor Daniel Tumas:

Title: Unveiling the Innovation of Daniel Tumas in Biotechnology

Introduction:

Daniel Tumas, a prolific inventor hailing from Orinda, CA in the United States, has made significant contributions in the field of biotechnology. With an impressive portfolio of 68 patents, Tumas is a trailblazer in developing novel solutions for degenerative cartilaginous disorders and inflammatory diseases.

Latest Patents:

Tumas' latest patents focus on nucleic acids encoding receptors for IL-17 homologous polypeptides and their therapeutic applications. These inventions involve novel polypeptides with sequence identity to IL-17, IL-17 receptors, and the corresponding nucleic acid molecules. The patents also encompass vectors, host cells, chimeric polypeptide molecules, and antibodies for producing and targeting the polypeptides in treating various medical conditions.

Career Highlights:

Throughout his career, Daniel Tumas has been associated with renowned companies such as Genentech, Inc. Tumas' expertise and groundbreaking innovations have significantly impacted the biotechnology industry, reshaping the landscape of medical treatments for complex disorders.

Collaborations:

In his ventures, Daniel Tumas has collaborated with esteemed professionals in the field, including Audrey Goddard and Austin L. Gurney. Together, they have pushed the boundaries of scientific research, driving forward impactful solutions for challenging health conditions.

Conclusion:

Daniel Tumas' dedication to innovation and relentless pursuit of advancements in biotechnology underscore his remarkable achievements in the realm of medical inventions. His groundbreaking patents and collaborative efforts stand as a testament to his commitment to improving healthcare practices and transforming the lives of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…